Evaluation of immunodiagnostic tests for human gnathostomiasis using different antigen preparations of Gnathostoma spinigerum larvae against IgE, IgM, IgG, IgG1-4 and IgG1 patterns of post-treated patients.

Objectives The aims of the study are twofold: (1) antigen (Ag) preparation and evaluation of three antigens of Gnathostoma spinigerum infective larvae (GsL3), crude somatic antigen (CSAg), excretory-secretory antigen (ESAg), and partially purified antigens (namely, P1Ag, P2Ag, and P3Ag) to differentiate IgE, IgG, IgG1-4, and IgM for human gnathostomiasis diagnosis; (2) application of the selected ELISA for following up stored sera of patients treated with ivermectin (IVM), and albendazole (ABZ). Methods Different antigens were analyzed by antibodies of gnathostomiasis cases, other parasite infections, and healthy controls using indirect ELISA to differentiate IgE, IgG, IgG1-4, and IgM. Then, prominent antigen and immunoglobulin were used in antibody predictions of gnathostomiasis cases treated with albendazole or ivermectin. Results Sensitivity of all evaluated ELISAs; IgM-, IgG-, IgG1- and IgG4-ELISA, was 100%. IgM-ELISA with CSAg and P3Ag exhibited the highest specificity of 99%. IgG-ELISA with P2Ag resulted in the highest specificity of 92.3%. IgG1-ELISA with P2Ag and P3Ag showed excellent results with 100% specificity. Finally, P2Ag evaluated IgG1 of the followed-up cases with ABZ and IVM. Decreasing antibody IgG1 levels were mostly found in both treatments at month 9 and long follow-up was over 12 months. A Gnathostoma worm was extracted from each two treated patients. Conclusions Using IgG1-ELISA against P2Ag and P3Ag gave excellent results with 100% sensitivity and specificity. These tests can be an alternative to immunoblotting for gnathostomiasis. IgG1 decreased at least 9 months in most cases, so long-term treatment should be performed over 1 year.